Creative Medical Technology (CELZ) Expected to Announce Quarterly Earnings on Friday

Posted by ABMN Staff on Mar 21st, 2025

Creative Medical Technology (NASDAQ:CELZ – Get Free Report) will likely be posting its quarterly earnings results before the market opens on Friday, March 28th. Analysts expect Creative Medical Technology to post earnings of ($0.63) per share for the quarter.

Creative Medical Technology Trading Down 8.3 %

Shares of NASDAQ CELZ opened at $2.78 on Friday. The firm has a market cap of $6.46 million, a PE ratio of -0.73 and a beta of 1.69. Creative Medical Technology has a 1-year low of $1.96 and a 1-year high of $6.90. The company has a fifty day moving average price of $3.75 and a 200 day moving average price of $3.27.

About Creative Medical Technology

(Get Free Report)

Creative Medical Technology Holdings, Inc, a commercial stage biotechnology company, focuses on novel biological therapeutics in the fields of immunotherapy, endocrinology, urology, neurology, and orthopedics in the United States. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; and StemSpine, a regenerative stem cell procedure to treat degenerative disc disease.